Team:RAMNOTIREN CALGARY/HumanPractices

From 2014hs.igem.org

(Difference between revisions)
Line 95: Line 95:
}
}
-
#footer {
 
-
border: none;
 
-
width: 850px;
 
-
margin: 0 auto;
 
-
padding: 0;
 
-
}
 
.firstHeading {  
.firstHeading {  
Line 115: Line 109:
}
}
-
.printfooter {
 
-
display: none;
 
-
}
 
-
 
-
#footer ul {
 
-
margin: 0;
 
-
padding: 0;
 
-
}
 
-
 
-
#footer ul li {
 
-
margin-top: 0;
 
-
margin-bottom: 0;
 
-
margin-left: 10px;
 
-
margin-right: 10px;
 
-
padding: 0;
 
-
}
 
#search-controls {  
#search-controls {  
Line 158: Line 136:
}
}
-
.plus {
+
                h7{
-
        display: inline-block;
+
                        font-size: 25.5px;
-
        -webkit-transition: 1s ease-in-out;
+
                        font-family: arial, verdana;
-
        -moz-transition: 1s ease-in-out;
+
                        color: #FFF;
-
        -o-transition: 1s ease-in-out;
+
                }
-
    }
+
 
-
     
+
                #sidebar{
-
    .menu:hover .plus {
+
                  /*
-
        -webkit-transform: rotate(1000deg);
+
                position: relative;
-
        -moz-transform: rotate(1000deg);
+
                top: 0px;
-
        -o-transform: rotate(1000deg);
+
                left: 0px;
-
    }
+
                */
 +
                width: 300px;
 +
                padding: 10px;
 +
                }
 +
 
 +
                #sidebar ul li{
 +
                        list-style-type: none;
 +
                        padding: 2px 0px 2px 0px;
 +
                }
 +
 
 +
                #sidebar ul li a{
 +
                        color: #FFF;
 +
                        font-family: arial, verdana, cambria;
 +
                        /*ffc750 yellow for hover color*/
 +
                                               
 +
                }
 +
 
 +
                #sidebar a{
 +
                        text-decoration: none;
 +
                }
 +
 
 +
                #sidebar a:hover{
 +
                        color: #ffc750;
 +
                }
 +
 
 +
                #list{
 +
                  position: relative;
 +
                  top: -220px;
 +
 
 +
                }
 +
 
 +
                #listt{
 +
                        padding-bottom: 20px;
 +
                       
 +
                }
 +
 
 +
/*                #hpprologue{
 +
                  position: relative;
 +
                  background-color: #E6E6E6;
 +
                  font-family: arial, verdana;
 +
                  border-radius: 3px;
 +
                  width: 900px;
 +
                  padding: 40px 40px 20px 40px;
 +
                }
 +
 
 +
                #hpprologue2{
 +
                  position: relative;
 +
                  background-color: #E6E6E6;
 +
                  font-family: arial, verdana;
 +
                  border-radius: 3px;
 +
                  width: 900px;
 +
                  padding: 40px 40px 20px 40px;
 +
                }
 +
 
 +
                #pietable{
 +
                  float: center;
 +
                }
 +
*/
Line 289: Line 324:
</header>
</header>
-
  </h2>
+
<div id="sidebar">
-
     <p>Pellentesque habitant morbi tristique senectus et netus et
+
    <img id="image" src="https://static.igem.org/mediawiki/2014hs/6/68/Sidebarimgft.jpg"/>
-
     malesuada fames ac turpis egestas. Vestibulum tortor quam,
+
  <ul id="list">
-
     feugiat vitae, ultricies eget, tempor sit amet, ante. Donec eu
+
     <div id="listt">
-
    libero sit amet quam egestas semper. Aenean ultricies mi vitae
+
      <h7>NOTEBOOK</h7>
-
    est. Mauris placerat eleifend leo. Quisque sit amet est et sapien
+
     </div>
-
    ullamcorper pharetra. Vestibulum erat wisi, condimentum sed,
+
      <li> <a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/Project/Content">Overview</a></li>
-
    commodo vitae, ornare sit amet, wisi. Aenean fermentum, elit eget
+
      <li> <a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/HumanPractices">Human Practices</a></li>
-
    tincidunt condimentum, eros ipsum rutrum orci, sagittis tempus
+
      <li> <a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/Project/Safety">Safety</a></li>
-
     lacus enim ac dui. Donec non enim in turpis pulvinar facilisis.
+
      <li> <a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/References">References</a></li>
-
     Ut felis. Praesent dapibus, neque id cursus faucibus, tortor
+
      <li> <a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/Attributions">Attributions</a></li>               
-
     neque egestas augue, eu vulputate magna eros eu erat. Aliquam
+
     </ul>
-
     erat volutpat. Nam dui mi, tincidunt quis, accumsan porttitor,
+
</div>
-
     facilisis luctus, metus.</p>
+
 
 +
<div id="hpprologue">
 +
  <p>For the human practices portion of our project we put up a survey online, getting 136 people to respond to the questions listed below: <br>
 +
  1. Have you or someone close to you ever been affected by cancer?<br>
 +
  2. Would you be comfortable having bacteria injected into your bloodstream if it could potentially treat or cure cancer?<br>
 +
  3. Would you still want to undergo this treatment if it meant suffering side effects such as fatigue and/or flu-like symptoms (i.e. nausea, vomiting, diarrhea, etc.)?<br>
 +
  4. Assuming similar success rates, would you prefer to undergo chemotherapy, or this bacterial treatment option?<br>
 +
  5. Would you choose this treatment option if the duration of the treatment was the same as that of traditional forms of treatment, such as chemotherapy?<br>
 +
  6. If this form of treatment took twice as long as traditional treatment options, but with higher success rates, would you still opt for this treatment?<br>
 +
  7. During treatment, would you be comfortable limiting/cutting out all physical activity?<br>
 +
  8. Would you support your tax dollars going towards developing this type of treatment?<br>
 +
  9. Identify your age range: 14-18, 19-24, 25-32, 41-51, 52+ </p><br><br>
 +
 
 +
  <p>We converted our survey information into a chart form and the results are as follows:</p><br>
 +
</div>
 +
 
 +
  <table id="pietable">
 +
     <tr>
 +
      <td><img src="graph1.jpg" width="600px" height="463px"/></td>
 +
      <td><img src="graph2.jpg" width="600px" height="463px"/></td>
 +
     </tr>
 +
 
 +
    <tr>
 +
      <td><img src="graph3.jpg" width="600px" height="463px"/></td>
 +
      <td><img src="graph4.jpg" width="600px" height="463px"/></td>
 +
     </tr>
 +
 
 +
    <tr>
 +
      <td><img src="graph5.jpg" width="600px" height="463px"/></td>
 +
      <td><img src="graph6.jpg" width="600px" height="463px"/></td>
 +
     </tr>
 +
 
 +
    <tr>
 +
      <td><img src="graph7.jpg" width="600px" height="463px"/></td>
 +
      <td><img src="graph8.jpg" width="600px" height="463px"/></td>
 +
     </tr>
 +
 
 +
    <tr>
 +
      <td><img src="graph9.jpg" width="600px" height="463px"/></td>
 +
      <td><img src="graph10.jpg" width="600px" height="463px"/></td>
 +
    </tr>
 +
 
 +
    <tr>
 +
      <td><img src="graph11.jpg" width="600px" height="463px"/></td>
 +
    </tr>
 +
 
 +
  </table>
 +
 
 +
<div id="hpprologue2">
 +
  <p>We found that openness for funding for this type of project was an overwhelming 95% of the people who’d taken the survey and that the majority of people were open to trying our type of treatment, especially if it proved to be more effective than chemotherapy.
 +
  The one major concern most people had was about the physical activity and how much physical activity they would have to limit for what periods of time.</p>
 +
</div>
 +
 
 +
 
</body>
</body>
</html>
</html>

Revision as of 07:51, 20 June 2014

For the human practices portion of our project we put up a survey online, getting 136 people to respond to the questions listed below:
1. Have you or someone close to you ever been affected by cancer?
2. Would you be comfortable having bacteria injected into your bloodstream if it could potentially treat or cure cancer?
3. Would you still want to undergo this treatment if it meant suffering side effects such as fatigue and/or flu-like symptoms (i.e. nausea, vomiting, diarrhea, etc.)?
4. Assuming similar success rates, would you prefer to undergo chemotherapy, or this bacterial treatment option?
5. Would you choose this treatment option if the duration of the treatment was the same as that of traditional forms of treatment, such as chemotherapy?
6. If this form of treatment took twice as long as traditional treatment options, but with higher success rates, would you still opt for this treatment?
7. During treatment, would you be comfortable limiting/cutting out all physical activity?
8. Would you support your tax dollars going towards developing this type of treatment?
9. Identify your age range: 14-18, 19-24, 25-32, 41-51, 52+



We converted our survey information into a chart form and the results are as follows:


We found that openness for funding for this type of project was an overwhelming 95% of the people who’d taken the survey and that the majority of people were open to trying our type of treatment, especially if it proved to be more effective than chemotherapy. The one major concern most people had was about the physical activity and how much physical activity they would have to limit for what periods of time.

Retrieved from "http://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/HumanPractices"